Chloroprocaine Hydrochloride Injection Shortage
Last Updated: April 10, 2023
Status: Current
Reason for the Shortage
-
- Fresenius Kabi had chloroprocaine on shortage due to increased demand.
- Hikma did not provide a reason for the shortage.
Available Products
-
- Nesacaine solution for injection, Fresenius Kabi, 1% (10 mg/mL), 30 mL multiple dose vial, 25 count, NDC 63323-0475-37
- Nesacaine solution for injection, Fresenius Kabi, 2% (20 mg/mL), 30 mL multiple dose vial, 25 count, NDC 63323-0476-37
- Nesacaine-MPF solution for injection, Fresenius Kabi, 2% (20 mg/mL), 20 mL preservative-free and EDTA-free single dose vial, 25 count, NDC 63323-0477-27
- Nesacaine-MPF solution for injection, Fresenius Kabi, 3% (30 mg/mL), 20 mL preservative-free and EDTA-free single dose vial, 25 count, NDC 63323-0478-27
- Chloroprocaine hydrochloride solution for injection, Hikma, 2% (20 mg/mL), 20 mL preservative-free and EDTA-free single dose vial, 10 count, NDC 00143-9209-10
- Chloroprocaine hydrochloride solution for injection, Hikma, 3% (30 mg/mL), 20 mL preservative-free and EDTA-free single dose vial, 10 count, NDC 00143-9210-10
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated April 10, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 15, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.